Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biodesix (BDSX)
NASDAQ:BDSX
Holding BDSX?
Track your performance easily
BDSX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.11 - $2.21
Previous Close$1.19
Volume5.23M
Average Volume (3M)287.11K
Market Cap
$180.38M
Enterprise Value$210.93M
Total Cash (Recent Filing)$31.41M
Total Debt (Recent Filing)$61.96M
Price to Earnings (P/E)―
Beta0.76
Next Earnings
Mar 18, 2025EPS Estimate
-$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding145,467,295
10 Day Avg. Volume629,606
30 Day Avg. Volume287,108
Standard Deviation0.23
R-Squared0.06
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)6.26
Price to Sales (P/S)2.75
Price to Cash Flow (P/CF)-4.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.22
Enterprise Value/Gross Profit5.85
Enterprise Value/Ebitda-8.01
Forecast
1Y Price Target
$3.13Price Target Upside160.83% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Biodesix News
PremiumCompany Announcements
Biodesix Reports Strong Q3 2024 Growth in Diagnostics
PremiumCompany Announcements
Biodesix Releases Updated Corporate Presentation Information
Bulls Say, Bears Say
Bulls Say
Reimbursement CoverageBiodesix's expanding sales force and new reimbursement coverage from additional payers should also drive continued top-line growth.
Revenue BacklogThe company exited 3Q with a biopharma revenue backlog of $11.1 million, compared to $8.1 million exiting 2Q24.
Sales GrowthSales force expansion should drive continued growth, with the company adding multiple sales representatives in 3Q24.
Bears Say
Biopharma ServicesBiopharma services revenues were below expectations despite solid order backlog growth.
Revenue PerformanceThird-quarter revenues were below estimates due to weather impacts and delays in sales representative hiring.
Weather ImpactBiodesix's performance was negatively impacted by severe hurricanes that recently occurred in the Southeast region of the U.S.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BDSX FAQ
What was Biodesix’s price range in the past 12 months?
Biodesix lowest stock price was $1.11 and its highest was $2.21 in the past 12 months.
What is Biodesix’s market cap?
Currently, no data Available
When is Biodesix’s upcoming earnings report date?
Biodesix’s upcoming earnings report date is Mar 18, 2025 which is in 116 days.
How were Biodesix’s earnings last quarter?
Biodesix released its earnings results on Nov 01, 2024. The company reported -$0.07 earnings per share for the quarter, beating the consensus estimate of -$0.073 by $0.003.
Is Biodesix overvalued?
According to Wall Street analysts Biodesix’s price is currently Undervalued.
Does Biodesix pay dividends?
Biodesix does not currently pay dividends.
What is Biodesix’s EPS estimate?
Biodesix’s EPS estimate is -$0.07.
How many shares outstanding does Biodesix have?
Biodesix has 145,467,300 shares outstanding.
What happened to Biodesix’s price movement after its last earnings report?
Biodesix reported an EPS of -$0.07 in its last earnings report, beating expectations of -$0.073. Following the earnings report the stock price went down -23.529%.
Which hedge fund is a major shareholder of Biodesix?
Among the largest hedge funds holding Biodesix’s share is Farallon Capital Management, L.L.C.. It holds Biodesix’s shares valued at 8M.
---
Biodesix Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$3.13 (160.83% Upside)
$3.13 (160.83% Upside)
Blogger Sentiment
Bullish
BDSX Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 2.8M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $656.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.0%
Last 30 Days ▲ 17.3%
Last 30 Days ▲ 17.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.19%
12-Months-Change
Fundamentals
Return on Equity
-331.82%
Trailing 12-Months
Asset Growth
18.39%
Trailing 12-Months
Company Description
Biodesix
Biodesix Inc is a data-driven diagnostic solutions company. The company's artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. The revenue is derived from two sources namely, providing diagnostic tests and providing biopharmaceutical companies with services that include diagnostic research, clinical research, development and testing services.
---
BDSX Earnings Call
Q3 2024
0:00 / 0:00
---
BDSX Stock 12 Month Forecast
Average Price Target
$3.13
▲(160.83% Upside)
Technical Analysis
Best Analysts Covering BDSX
1 Year
1 Year Success Rate
1/7 ratings generated profit
1 Year Average Return
-49.90%
reiterated a buy rating 18 days ago
Copying Sung Ji Nam's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -49.90% per trade.
---